We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+32.33%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$120M
AUM Growth
–
Cap. Flow
+$112M
Cap. Flow %
93.19%
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GNCA
Genocea Biosciences, Inc.
GNCA
+$32.6M
2
TRVN
Trevena, Inc.
TRVN
+$29.9M
3
BIND
BIND THERAPEUTICS INC
BIND
+$26.4M
4
FATE icon
Fate Therapeutics
FATE
+$19.1M
5
TWTR
Twitter, Inc.
TWTR
+$4.18M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 77.06%
2 Communication Services 2.86%
3 Technology 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GNCA
1
DELISTED
Genocea Biosciences, Inc.
GNCA
$38.7M 32.16%
+266,085
New +$32.6M
TRVN
2
DELISTED
Trevena, Inc.
TRVN
$30M 24.89%
+6,099
New +$29.9M
BIND
3
DELISTED
BIND THERAPEUTICS INC
BIND
$24.1M 20.05%
+2,018,253
New +$26.4M
FATE icon
4
Fate Therapeutics
FATE
$275M
$24.1M 20.01%
+2,473,186
New +$19.1M
TWTR
5
DELISTED
Twitter, Inc.
TWTR
$3.45M 2.86%
+73,844
New +$4.18M
TRLA
6
DELISTED
TRULIA INC (DEL)
TRLA
$34K 0.03%
+1,032
New +$34.8K

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q1 2014 Portfolio in Review

Q1 2014 is the first quarter with a 13F filing on record for Polaris Venture Management Co V, which disclosed 6 positions worth $120M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Genocea Biosciences, Inc.: 266,085 shares worth $38.7M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, followed by Communication Services and Technology.

  • Polaris Venture Management Co V's largest Q1 2014 buy was Genocea Biosciences, Inc.: 266,085 shares worth $38.7M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $120M portfolio in Q1 2014.
  • Polaris Venture Management Co V disclosed 6 positions in Q1 2014, its first 13F filing on record.

Based on Polaris Venture Management Co V's 13F filing for Q1 2014, filed 1 May 2014.